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As a nanotechnology has been actively applied to the overall 
areas of scientific fields, it is necessary to understand the 
characteristic features, physical behaviors and the potential 
effects of exposure to nanomaterials and their toxicity. In this 
article we review the immunological influences induced by 
several nanomaterials and emphasize establishment of the 
animal models to estimate the impact of these nanomaterials 
on development of immunological diseases. 
[Immune Network 2010;10(3):85-91]
INTRODUCTION
A nanotechnology which has appeared since the mid-twenties 
century has provided the methods by which the limitations 
in  the  industrial  application  of  each  scientific  technology 
could be overcome. It has also brought another revolutionary 
change to the overall areas in the scientific technology and 
the related industries. A nanotechnology has become a basis 
of the integrated development of scientific technology which 
has independently been developed. It has also been actively 
applied to the overall areas of scientific fields. The character-
istics of nanomaterials are subject to their surface property, 
according  to  which  the  desirable  physical  property  can  be 
given  deliberately  to  them. 
    As  described  here,  products  manufactured  using  nano-
materials are characterized to overcome the areas which can-
not be resolved with the previous technology. It can therefore 
be  stated  that  they  have  a  higher  degree  of  applicability. 
Synchronously, there is an increasing concern that they would 
be new hazardous factors for both humans and nature (1). 
In  identifying  and  then  clarifying  risks  due  to  exposure  to 
nanomaterials, it is extremely important to clarify the phys-
icochemical property and physical behavior of nanomaterials 
and to understand the biological and physiological actions of 
them  in an  in vivo setting (2). Based on this, a systematic 
approach  should  be  made  to  examine  the  possible  detri-
mental effects on the production, environment and health. In 
general, methods for assessing the detrimental effects of con-
ventional types of  chemicals  are divided  into the  definition 
of detrimentalness, the assessment of dose-response, that of 
exposure and that of detrimental characteristics. These meth-
ods can also be applied to nanomaterials. In nanomaterials, 
however, as their surface area is increased, their responsive-
ness and toxicity to viable tissues are also increased (3). It 
is of prime importance to clarify new physicochemical prop-
erty  and  to  evaluate  the  resulting  toxicity  of  them. 
Accordingly  in  the  assessment  of  detrimentalness  of  nano-
materials, it is necessary to understand the characteristic fea-
tures, physical behaviors, the potential effects of exposure to 
nanomaterials  and  their  toxicity  (4). 
IMMUNOLOGICAL EFFECTS OF NANOMATERIALS
Nanomaterials have a structure that the size of one of three 
surfaces is 1∼100 nm according to the definition made by 
ISO/TC 229. As described here, based on a smaller size of 
＜100  nm,  nanomaterials  have  physicochemical  properties 
which  are  greatly  different  from  general  types  of  other 
substances. Due to a higher degree of surface reactivity and 
the cell membrane permeability, an  in vivo influx of nano-
m a t e r i a l s  p r o d u c e s  t h e  s t r e s s  o n  a  c e l l u l a r  l e v e l .
    Until the year of 2006, 69% of total manuscripts published 
on a peer-reviewed journal are related to the toxicity and the 
remaining  31%  are  related  to  the  exposure.  In  particular, Nanomaterials and Immune System
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Table I. Immunotoxicity of carbon-based nanomaterials
Nanomaterials 　　　Summary Reference no.
Carbon black (<100 nm) Induction of MCP-1, CCL2, IL-6, C-reactive protein and 25
  exaggeration of arthrosclerosis in animals
Carbon black (14 nm) Induction of slight expression of CD80 and MHC class II 26
  and significant expression of CD86 and DEC205 in endothelial cells
Single-walled carbon nanotubes  Persistence of SWNT for several months in kidney and liver 27
  (PEG coating 1∼5 nm in diameter,   without obvious toxicity
  50∼200 nm in length)
Single-walled carbon nanotubes Biodegradation of single-walled carbon nanotubes by hypochlorite and 28
  (1∼4 nm in diameter)   ROS mediated byf human neutrophil myeloperoxidase 
Single-walled carbon nanotubes Induction of ROS, inflammatory cytokines and expression of apoptosis 29
  (1∼2 nm in diameter 20 nm-several   related genesin macrophages
  μm in length)
Single-walled carbon nanotubes Inhibition of production of IL-8, 6, TNF-α and  MCP-1 in A549 cells 30
  (800 nm length)
Multi-walled carbon nanotubes Induction of fibrosis in asthma animal model and suggestion of the role 31
  (10∼30 nm in diameter   of  TGF-β and PDGF
  30∼50 nm in length)
Multi-walled carbon nanotubes Induction of ROS, inflammatory cytokines and activation of NF-kB 32
  (20∼40 nm in diameter,   in A549 or BEAS-2B cells
  5∼30μm in length)
C60 fullerene (0.7 nm in diameter) No toxicity in animal lung 33
since  2008,  research  articles  about  the  toxicity  have  been 
abruptly increased. These articles have reported the pulmo-
n a r y  t o x i c i t y ,  n e u r o t o x i c i t y  a n d  t h e  p e r m e a b i l i t y  t o  b l o o d -  
brain-barrier.  Besides,  peer-reviewed  articles  about  the  im-
munotoxicity  have  also  been  increasingly  published.
  Nanomaterials are crystalline, fine particles with a large sur-
face area, and they have a higher degree of surface charge 
and proton exchangeability. Besides, it is also expected that 
they might have a positive effect on the environment because 
they facilitate the synthesis and transportation of contaminants 
i n  t h e  e n v i r o n m e n t .  I n  a d d i t i o n ,  t h e  p o t e n t i a l  p r o b l e m s  o f  
nanomaterials are not limited to the environmental pollution. 
By various routes such as an inhalation, they are absorbed 
into the body and then induce the biological toxicity (5,6). 
T h i s  m a k e s  n a n o m a t e r i a l s  f u r t h e r  i n t e r e s t i n g .  T h e  p o s s i b l e  
routs by which nanomaterials migrate in the human body in-
clude  the  following:
    1) Endocytosis: Nanomaterials enter the cells when they are 
surrounded  by  the  cell  membrane  without  passing  it.
    2) Cell membrane penetration occurring with the action of 
hydrophobic  particles.
  3) Transportation of nanoparticles with a size of ＜5 nm 
across  the  cell  membrane  channel.
    As  described  here,  it  has  been  proposed  that  the  con-
tactable nanoparticles might stimulate the immune system in 
the body. By  contrast,  recent  studies have  been conducted 
to  examine  industrial  nanoparticles.  Industrial  nanoparticles 
are mainly contacted in a working place by daily commodities 
or pharmaceutical products in  customers. The total  amount 
of exposure may be relatively lower or the actual one occur-
ring  in  the  local  tissue  might  be  relatively  higher. 
Nanoparticles produce oxygen radicals (7,8). Besides, the mi-
tochondrial  perturbation  and  apoptosis  (9)  are  induced, 
which  are  followed  by  the  cytotoxicity.  With  the  reactions 
with body proteins and other biological substances, various 
types  of  hazardous  reactions  might  occur.
    One of the advantages of nanoparticles, a biological perme-
ability makes an intracellular and intranuclear influx of nano-
materials possible. Based on these findings, it has therefore 
been postulated that the oxidative stress and inflammatory re-
sponses induce the occurrence of immunotoxicity directly or 
indirectly.  It  is  therefore  imperative  that the  technology for 
assessing the exposure be established to examine the phys-
icochemical properties of nanomaterials and to clarify the re-
lated  immunotoxic  mechanisms.
    Peer-reviewed articles about the toxicity of nanomaterials Nanomaterials and Immune System
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Table II. Immunotoxicity of metal-based nanomaterials
Nanomaterials Summary Reference no.
TiO2 (0.02∼0.03μm) Induction of ROS but not TNF-α in respiratory epithelial cells 34
TiO2 (4∼6 nm, rutile) Induction of monocytes and lung inflammation, cardiac edema and 35
  systemic inflammation but decrease of platelets
TiO2 (20 nm) Engulfment of TiO2 by alveolar macrophages within24 hours in animal treatment 36
TiO2 (15, 50, 100 nm) Induction of histamine release without allergens 37
TiO2 (<100 nm) Induction of apoptosis and necrosis in macrophage cells 38
Gold (13 nm) Induction of apoptosis and acute inflammation in liver and localization of 39
  nanoparticles in Kupffer cells of liver and macrophages in spleen
Gold (2, 40 nm) Internalization by both microglial cells and primary hippocampal neurons and 40
  toll-like receptor 2 up-regulation in the olfactory bulb;
  up-regulation of TLR-2, IL-1α, GM-CSF and nitric oxide in microglia
Gold (0.8∼15 nm)  No changes in mRNA induction of pro-inflammatory (TNF-α, IL-8, iNOS) and 41
  oxidative stress markers (HO-1, SOD) as well as IL-1, IL-2, IL-4, IL-6, IL-8, IL-10,
  GM-CSF, TNF-α, INF-γ
Fe2O3 Induction of pro-inflammatory cytokines (IL-1, TNF-α, IL-6), TH0 cytokine (IL-2), 42
  TH1 type cytokine (IL-12), TH2 type cytokines (IL-4, IL-5), TGF-α and IgE
Fe2O3  Decrease in cell viability associated with significant increases in lactate 43
  dehydrogenase activity, IL-1α and ferritin expression
Zinc oxide (11 nm), Induction of ROS, apoptosis and inflammation by ZnO but  inhibition of ROS by CeO2 44
  cerium oxide (8 nm)
Table III. Immunotoxicity related of silica or polystyrene-based nanomaterials
Nanomaterials Summary Reference no.
Silicon No acute irritation in HaCaT keratinocytes, a human skin equivalent 45
  model (HSEM), and in vivo mouse model 
Silica particles (12 nm)  Increased blood level of IL-1β and TNF-α in blood, and increased release of 46 
  nitric oxide released from peritoneal macrophages; increased.
  mRNA expressions of IL-1, IL-6, TNF-α, iNOS, and COX-2 
Silica (70, 300, 1,000 nm) Induction of liver damage and inflammatory cytokines by 70 nm particles, 47
  but not 300 or 1,000 nm particles
Polystyrene (60 nm) Highly toxic to BEAS-2B cells, human microvascular endothelial cells, 48
     hepatoma cells, microvascular endothelial cells and macrophages 
Polystyrene nanoparticles Uptake of polystyrene nanoparticles by dendritic cells and migration of dendritic 49
  (20, 500, 1,000 nm)    cells to lymph nodes
Latex nanomaterial Induction of fibrinogen, MCP-1 by 25 or 50 nm particles, but not by 50
  (25, 50, 100 nm)   100 nm particles
have been summarized based on the chemical constituents. 
Based on the classification system into carbon nanomaterials, 
metals, metal-oxide nanomaterials and other silicas, a review 
of the above peer-reviewed journals was made. Results were 
represented in Tables I, II and III. For example, of carbon 
nanomaterials, carbon black induces the immune responses. 
In particular, multi-walled carbon nanotubes (MWCNT) rather 
than single-walled carbon nanotubes (SWCNT) induce the ac-
tivation of immune responses to a greater extent (Table I). 
Of metals and metal oxides, iron oxide nanoparticles strongly 
induce the immune responses. Besides, gold nanoparticles in-
duce a moderate degree of the immune responses. Further-
more, TiO2 induces a lower degree of the immune responses 
(Table  II).  In  addition,  it  has  also  been  reported  that  such 
substances as silica, polystyrene and latex nanomaterials have 
an  immunotoxicity  (Table  III).Nanomaterials and Immune System
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Figure 1. Potential contribution of nanomaterials on asthma patho-
physiology.
THE NECESSITY FOR CONDUCTING STUDIES 
ABOUT THE RELATEDNESS TO DISEASE THROUGH 
AN ANIMAL EXPERIMENTAL MODEL OF 
PULMONARY DISEASES IN AN IN VIVO SETTING
Relatedness  of  nanomaterials  to  diseases  can  be  presumed 
based on studies about the particulate matter (PM) associated 
with air pollution and the diseases (10-12). A long-term ex-
posure to particulate matter (PM) increases the incidence of 
complications  associated  with  pulmonary  (13,14)  and  car-
diovascular diseases (15) and the resulting mortality. The oc-
currence of malignant mesothelioma due to an inhalation of 
asbestos fiber (16,17), which has become a socially issue in 
recent  years,  well  illustrates  the  hazardousness  of  micro-
particles. Particulate matters (PM10) of ＜10μm in size are 
associated with respiratory diseases such as asthma, chronic 
o b s t r u c t i v e  p u l m o n a r y  d i s e a s e  ( C O P D ) ,  a c u t e / c h r o n i c  b r o n-
chitis and lower respiratory tract diseases and cardiovascular 
diseases  such  as  myocardial  infarction,  arrhythmias  and 
arteriosclerosis. Besides, particulate matters (PM2.5) of ＜2.5 
μm in size have a poorer effect on the respiratory system 
and cardiovascular one as compared with PM10 and they also 
raise the mortality. An analysis was performed for the correla-
t i o n  b e t w e e n  t h e  c o n c e n t r a t i o n  o f  P M 2 . 5  a n d  t h e  m o r t a l i t y 
in the USA, according to which 100,000 people are found to 
die  directly  or  indirectly  due  to  PM2.5  every  year. 
  The number of particulate matters in the atmosphere has 
been reported to be associated with the occurrence of respira-
t o r y  d i s e a s e s .  S i n c e  t h e n ,  i t  h a s  b e e n  p r o p o s e d  t h a t  n a n o-
particles  inhaled  through  a  mathematical  model  of  the  ex-
pansion of human lungs might be deposited in an area rang-
ing from the trachea to terminal bronchioles. The surface area 
of particles rather the amount of particles are associated with 
the occurrence of inflammatory responses. At the present, no 
studies have provided the possibility that carbon nanotubes, 
nano-fibers and nano-wire products might induce the detri-
mentalness  to  such  an  equivalent  extent  to  asbestos. 
Nevertheless, to rule out this possibility, it is imperative that 
the safety following a long-term exposure to above materials 
be audited. An experimental animal model of a long-term ex-
posure  would  therefore  be  mandatory.
    Nanoparticles contained in particulate matter are known as 
a strong inducer of oxidative stress in macrophages and epi-
thelial cells lining the airway tract. They increase the activity 
such  molecules  as  MAP  kinase,  NF-κ B  and  AP-1  and  also 
promotes the synthesis of oxygen radicals (18,19). This phe-
nomenon  is  explained  as  one  of  the  key  pathophysiologic 
mechanisms by which COPD occurs, one of the representa-
tive  chronic  inflammatory  respiratory  tract  diseases.  It  has 
been  hypothesized  that  COPD  might  be  a  type  of  dust-in-
duced diseases. In this regard, the use of particulate matters 
and biomass fuel which has recently been of increasing inter-
est  has  been  considered  as  a  pathogenesis  of  COPD. 
Nanoparticles contained in the atmosphere have a possibility 
for  aggravating  the  respiratory  diseases. 
    In a murine model of asthma, one of the respiratory dis-
eases,  particulate  matter  of  0.2∼10μm  in  size  was  ex-
perimentally administered. According to this experiment, as 
the size of particles was relatively smaller, the deposition to 
the lower respiratory tracts was increased. Following the ad-
ministration  of  microparticles  into  the  airway  tract  in  the 
above  experimental  model,  the  concentration  of  protein  in 
the bronchoalveolar lavage is increased (20) and this is also 
accompanied by the increased occurrence of eosinophilic and 
neutrophilic inflammations occurring in the airway tract and 
the elevated levels of TH2 cytokines (IL-4, IL-5 and eotaxin) 
(21,22) as well as TH1 cytokines (IFN-γ, IL-6 and TNF-α) 
(23).  Besides,  following  an  intranasal  administration  of  oil 
flash ash, a key substance for pathological phenomena due 
to particulate matters in a murine model of asthma, the occur-
rence  of  respiratory  hypersensitivity  and  eosinophilic  in-
f l a m m a t i o n  w a s  f u r t h e r  i n c r e a s e d  ( 2 4 ) .
    In regard to the effects of nanoparticles on the asthma, a 
murine model of albumin-induced asthma has shown that the 
inflammatory  responses  and  the  production  of  immunoglo-
bluins were increased by nanoparticles in the respiratory tract 
(Fig.  1).  These  inflammatory  phenomena  are  explained  by 
the expression of IL-5 and eotaxin which was induced in the Nanomaterials and Immune System
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early stage of inflammation. Subsequently, with the induced 
expression of such cytokines as IL-13, RANTES and MCP-1, 
the degree of inflammation was further increased. Moreover, 
based  on  the  reports  that  TiO2  which  has  frequently  been 
used for cosmetic products aggravates the atopic dermatitis, 
it has been proposed that nanoparticles might aggravate the 
immune  diseases.
    In conclusion, with the development of nanotechnology, a 
great  deal  of  nanoproducts  and  the  related  materials  have 
been produced. Due to a lack of the clarification of the po-
tential  hazard  of  technical  development,  however,  demand 
and  supply  of  the  products  have  not  been  activated  up  to 
present. At the present, therefore, if guidelines or landmarks 
should be provided for safety assessment or data about the 
safety range including the immune toxicity of nanomaterials, 
this  would  greatly  contribute  to  the  activation  of  nanoin-
dustry.
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